DCM
ABBV icon

DGS Capital Management’s AbbVie ABBV Stock Holding History

DGS Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.47M Buy
6,748
+517
+8% +$115K 0.24% 79
2025
Q4 		$1.42M Buy
6,231
+334
+6% +$76.1K 0.24% 74
2025
Q3 		$1.37M Buy
5,897
+663
+13% +$135K 0.25% 71
2025
Q2 		$972K Buy
5,234
+724
+16% +$135K 0.2% 97
2025
Q1 		$945K Buy
4,510
+1,009
+29% +$196K 0.25% 81
2024
Q4 		$622K Buy
3,501
+140
+4% +$25.7K 0.16% 130
2024
Q3 		$664K Buy
3,361
+371
+12% +$69.2K 0.18% 118
2024
Q2 		$513K Sell
2,990
-289
-9% -$47.9K 0.14% 135
2024
Q1 		$597K Buy
3,279
+814
+33% +$140K 0.17% 115
2023
Q4 		$382K Sell
2,465
-170
-6% -$24.8K 0.15% 134
2023
Q3 		$393K Buy
2,635
+228
+9% +$33.5K 0.19% 123
2023
Q2 		$324K Sell
2,407
-3
-0.1% -$440 0.16% 142
2023
Q1 		$384K Sell
2,410
-152
-6% -$23.2K 0.21% 105
2022
Q4 		$414K Buy
2,562
+130
+5% +$19.9K 0.27% 91
2022
Q3 		$326K Buy
2,432
+193
+9% +$27.7K 0.22% 104
2022
Q2 		$343K Buy
2,239
+586
+35% +$89.5K 0.28% 86
2022
Q1 		$268K Buy
+1,653
New +$240K 0.16% 138

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DGS Capital Management's ABBV Position: Q1 2026 in Review

DGS Capital Management increased its AbbVie (ABBV) stake by 8.3% in Q1 2026, buying an estimated $115K and bringing the position to 6,748 shares worth $1.47M. The position accounts for 0.24% of the portfolio, ranked #79.

DGS Capital Management first reported a position in ABBV in Q1 2022 and has held it in 17 quarters since. 4,103 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • DGS Capital Management held 6,748 shares of AbbVie worth $1.47M as of Q1 2026.
  • DGS Capital Management bought 517 AbbVie shares in Q1 2026, an estimated $115K.
  • AbbVie made up 0.24% of DGS Capital Management's portfolio in Q1 2026, its #79 holding.
  • DGS Capital Management first reported a position in AbbVie in Q1 2022 and has held it in 17 quarters since.
  • 4,103 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.